Anastasiia Kotaieva Sells 30,000 Shares of Nukkleus (NASDAQ:NUKK) Stock

Posted by Defense World Staff on Jan 2nd, 2026

Nukkleus Inc. (NASDAQ:NUKK – Get Free Report) insider Anastasiia Kotaieva sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $4.41, for a total value of $132,300.00. Following the sale, the insider owned 1,331,197 shares of the company’s stock, valued at $5,870,578.77. The trade was a 2.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Anastasiia Kotaieva also recently made the following trade(s):

On Monday, December 29th, Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock. The shares were sold at an average price of $4.09, for a total value of $306,750.00.
On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.26, for a total transaction of $236,873.04.
On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total transaction of $249,661.96.
On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.57, for a total transaction of $319,900.00.
On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total transaction of $317,100.00.
On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The stock was sold at an average price of $4.72, for a total transaction of $182,871.68.

Nukkleus Stock Performance

Shares of NASDAQ NUKK opened at $4.03 on Friday. Nukkleus Inc. has a 12-month low of $3.31 and a 12-month high of $40.98. The stock has a market cap of $67.10 million, a PE ratio of 0.25 and a beta of -6.66. The company has a 50-day moving average of $5.53 and a 200 day moving average of $6.75.

Institutional Trading of Nukkleus

Institutional investors have recently made changes to their positions in the company. UBS Group AG lifted its holdings in Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after acquiring an additional 15,223 shares during the last quarter. Ausdal Financial Partners Inc. acquired a new stake in Nukkleus during the third quarter worth $105,000. Finally, BNP Paribas Financial Markets purchased a new stake in Nukkleus in the second quarter valued at $56,000. Hedge funds and other institutional investors own 12.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a report on Wednesday, December 24th. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nukkleus presently has a consensus rating of “Sell”.

Read Our Latest Research Report on NUKK

Nukkleus News Roundup

Here are the key news stories impacting Nukkleus this week:

Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established vendor relationships (IAI, Elbit, Rafael). This expands Nukkleus’s product set and creates a pathway to defense-market revenue. Nukkleus Completes Tiltan Acquisition
Neutral Sentiment: Major outlets (MSN, TipRanks) circulated the acquisition news, increasing visibility; however, the announcements lack financial detail (purchase price, projected revenue, integration plan), so near‑term earnings impact is uncertain. TipRanks Announcement
Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold several large blocks across Dec. 18–29 totaling roughly 286,208 shares for about $1.25M in proceeds (sales at ~$4.09–$4.72). Concentrated insider disposals can create selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.